Pharmaverse Podcast

Michael Pietrack

The Pharmaverse is a leadership podcast that brings you exclusive insights from the stars of the Pharma universe. Hosted by Michael Pietrack, a top Pharma and Biotech recruiter, whose team partners with the most recognizable Pharma companies in the industry, as well as the hottest of the emerging Biotechs. In each episode, Michael sits down with influential and innovative leaders in the Pharmaceutical and related industries. Listeners will hear from stars from all sectors of the Pharmaverse and will gain valuable insights to help lead their team or structure their careers. Whether you're a current leader, an aspiring leader, or a leadership enthusiast, the Pharmaverse Podcast has something for you. Tune in and subscribe!

Subscribe Listen in podnod RSS feed Show website

66 episodes
Updated Yesterday

Episodes66

Newest first

Jan 20, 2025 · 30 min
Season 2, Episode 2: Keys to Effective Leadership with Rob Abbott
Welcome back to the Pharmaverse Podcast! In episode 2 of Season 2, our host Michael Pietrack interviews Rob Abbott, CEO of ISPOR, discussing the significance of Health Economics and Outcomes Research (HEOR) in the pharmaceutical industry. There is a LOT to learn here, so buckle up for a great episode! They explore ISPOR's role in influencing health policy, the implications of the Inflation Reduction Act, and the balance between drug affordability and innovation. Abbott emphasizes the importance of evidence-based decision-making in healthcare and the evolving landscape of reimbursement strategies, including the impact of AI. The conversation also touches on ISPOR's future vision and leadership insights for driving change within organizations. What makes a truly effective leader? Rob shares that trust and authenticity are the non negotiable elements of a true leader. Tune in to this phenomenal episode, and be sure to share your comments below! Takeaways: 🤵ISPOR is the leading professional society for HEOR. 💲HEOR provides critical evidence for market access and pricing. 🔬Government agencies need accessible scientific evidence for policy decisions. 📈The Inflation Reduction Act marks a significant shift in drug pricing. Balancing affordability and innovation is crucial for the pharmaceutical industry. 💳Outcomes-based contracts are gaining traction in reimbursement strategies. 🩺AI can enhance data analysis and patient outcomes in healthcare. 👨‍⚕️ISPOR aims to transform healthcare accessibility and effectiveness. ▶The pharmaceutical industry will see new players and continued innovation. 🤝Trust and authenticity are key to effective leadership. Chapters: 00:00 Introduction to ISPOR and HEOR 07:31 Impact of the Inflation Reduction Act 13:12 Innovative Reimbursement Strategies 20:50 The Future of Pharma 25:52 Leadership Insights for Change
Jan 13, 2025 · 27 min
Season 2: Episode 1, Deep Dive on AI in Pharma with Dave Latshaw
We are thrilled to be bringing you our very first episode of season 2!! Thank you to all our longtime subscribers, and everyone who has been following along as we have grown this podcast! In today’s episode of the Pharmaverse podcast, host Michael Pietrack interviews Dave Latshaw PHD, MBA, the brilliant CEO and co-founder of BioPhy, about the transformative role of AI in drug discovery and development. They discuss the differences between predictive and generative AI, the impact of AI on jobs in the pharmaceutical industry, and the future applications of AI in drug development. Michael asks Dave the question on everyone’s mind, "Is AI going to eliminate a lot of jobs?" While Dave mentioned that many will loose jobs, he believes the Pharma sector will not experience this on a large scale, and that those that learn to utilize AI as an intern or sorts, will find a lot of success. “Think of AI as an intern.” Latshaw shares insights from his career journey, including his transition at Johnson & Johnson to deciding to go out on his own and found BioPhy, and emphasizes the importance of understanding the unique challenges and opportunities within the pharma sector. There is SO much to learn in this episode, please comment below and share your thoughts with us! Key Moments: 💻 AI is a powerful tool in drug discovery and development. 👩‍💻👨‍💻Generative AI and predictive AI are fundamentally similar. 📝AI will not eliminate jobs in the pharmaceutical industry. ⚙ The complexity of human health requires human oversight in AI applications. 💉AI can help identify new uses for existing drugs. 🤵Regulatory bodies will play a crucial role in AI integration. 🏥 AI's impact on productivity in drug development is significant. 🤝 Companies are more likely to partner for AI solutions than build in-house. Understanding the specific problems AI can solve is key to its adoption. ❓The journey from corporate to startup can lead to greater impact. Chapters 00:00 Introduction to AI in Drug Discovery 02:54 Understanding AI: Predictive vs Generative 05:56 AI's Impact on Jobs in Pharma 08:58 Current and Future Applications of AI in Pharma 12:03 The Role of Regulators in AI Integration 15:15 Identifying Opportunities in Shelved Drugs 17:48 Differentiating AI Solutions in Pharma 21:00 Dave Latshaw's Journey from J&J to BioFi 24:09 Navigating Challenges in the Pharma Industry
Dec 9, 2024 · 30 min
Season 1, Episode 24: Advice For Up-And-Coming Leaders with Pritesh Gandhi
Welcome back to the incredible Pharmaverse podcast where we sit down with the brightest stars in Pharma. In this episode of the Pharmaverse podcast, host Michael Pietrack interviews Pritesh Gandhi, CEO of TellBio, discussing his journey in the pharmaceutical industry, the challenges currently facing the sector, and the importance of communication and leadership. Pritesh shares insights on the impact of COVID-19 on clinical trials, the future of pharma amidst economic pressures, and the role of AI in diagnostics and therapeutics. He emphasizes the need for innovation and effective communication as key components of successful leadership. “Every day is different as a CEO” Pritesh stresses the importance of communication with all stakeholders, how to manage effectively, and how we can get Pharma out of its current funk. Learn about advice for up and coming leaders and more! Tune in, and be sure to like, comment, and subscribe for more Pharma content just like this. Key Moments:🔑 🥇 Pritesh Gandhi shares his unexpected journey to becoming a CEO of TellBio. 🤠 The role of a CEO involves wearing multiple hats and facing diverse challenges. 📈 Current economic factors like inflation are impacting pharma investments. 🤧 COVID-19 created significant challenges for clinical trials and innovation. 💲The IRA is influencing long-term budgeting and access to therapies. 🅰ℹ AI has the potential to revolutionize diagnostics and personalized medicine. 💉The diagnostic sector faces substantial headwinds, particularly in oncology. 📱 Effective leadership hinges on consistent and clear communication. 🌀Aspiring leaders should advocate for themselves and seek feedback. 🤝Understanding the difference between managing and leading is crucial for new managers. Chapters 00:00 Introduction to Pritesh Gandhi and TellBio 01:30 The Role of a CEO in Pharma 04:07 Current Challenges in the Pharmaceutical Industry 08:13 Impact of COVID-19 on Clinical Trials 10:18 Long-term Budgeting and the IRA 11:34 Future Challenges for Pharma 13:11The Role of AI in Diagnostics and Therapeutics 17:17Headwinds in the Diagnostic Sector 20:09 Key Qualities of Effective Leadership 26:10 Advice for Aspiring Leaders 28:24 Managing vs. Leading: Insights for New Managers
Nov 18, 2024 · 25 min
Season 1, Episode 23: Revolutionizing Cancer Treatment with Paul Romness
Episode 23: ADC Technology- Revolutionizing Cancer Treatment with Paul Romness Welcome back to the Pharmaverse, where we speak to the greatest voices in Pharma, to learn from their leadership and incredible careers! In this episode of the Pharmaverse podcast, host Michael Pietrack interviews Paul Romness, CEO of OS Therapies. The conversation delves into the inspiring story behind OS Therapies, which was founded in response to the osteosarcoma diagnosis of Olivia, a close friend of Paul’s daughter. We talk how to build incredible cultures! "The culture is set by the mission.” Paul discusses the innovative HER2 technology being developed to treat osteosarcoma and the importance of nonprofit partnerships in advancing research. He also shares insights into the ADC technology and its potential applications in cancer treatment. Throughout the discussion, Paul emphasizes the significance of leadership, company culture, and the personal sacrifices made in pursuit of a mission-driven approach to improving patient outcomes. Tune in to listen to the most incredible episode! 🟨 Takeaways 👧 OS Therapies was inspired by a personal story of a young girl named Olivia. 🧬 The HER2 technology aims to enhance overall survival rates in osteosarcoma patients. 📚 Nonprofit partnerships play a crucial role in funding and advancing research. 💉 ADC technology is a promising area in cancer treatment. ✅❌Leadership is shaped by experiences with both good and bad mentors. 🩺Company culture is driven by a mission focused on patient care. 🤝Hiring the right people is essential for maintaining a strong culture. •📱Networking is vital for finding passionate individuals to join the team. 💞Personal sacrifices are often necessary to pursue meaningful work. 🥅The ultimate goal is to improve treatment outcomes for pediatric cancer patients. 🟨 Chapters 00:00 Introduction to OS Therapies and Olivia's Story 02:59 Innovative HER2 Technology and Clinical Trials 06:06 Nonprofit Partnerships and Their Impact 08:48 ADC Technology and Its Applications 12:02 Career Journey and Leadership Insights 18:03 Building Culture, Hiring, and Networking 24:03 Personal Sacrifices and Mission-Driven Leadership
Nov 4, 2024 · 28 min
Season 1, Episode 22: The Process of Getting Promoted with Angela Justice
Episode 22: Demonstrating Value and Building Support with Angela Justice Welcome back to the Pharmaverse podcast! This week you will be learning a LOT. In this episode, Angela Justice, former chief people officer and head of medical affairs at TCR Squared, shares insights on how to position yourself for a promotion. She emphasizes the importance of mindset and shifting from a focus on effort and tenure to a focus on adding value. Angela outlines a three-step plan for creating value: finding a problem worth solving, laying the foundation by gaining alignment and support, and making your case by demonstrating the value you can provide. She also discusses the power of networking, the need for an enterprise view, and the development of soft skills for effective leadership. 🟨 Takeaways: 🧠Shift your mindset from effort and tenure to adding value in order to position yourself for a promotion. 🗺 Find a problem worth solving and gain alignment and support from stakeholders to lay the foundation for creating value. 👨‍✈️ Demonstrate the value you can provide through pilot programs and presentations to make your case for a promotion. 🌏Networking is crucial for gaining an enterprise view and developing connections that can lead to opportunities. 📍Developing soft skills, such as emotional intelligence and collaboration, is essential for effective leadership. Be sure to check out Angela's incredible content 👇 Free Promotion Playbook: https://pages.justicegroupadvisors.co... Angela’s website: https://www.justicegroupadvisors.com 🟨 Chapters 00:00 Introduction and Guest Introduction 03:11 Step 1: Finding Problems Worth Solving 08:44 Step 3: Making Your Case for a Promotion 14:05 The Power of Networking and Developing an Enterprise View 19:08 Qualities of Great Leaders and Exporting Talent 23:50 Developing Soft Skills for Effective Leadership 25:54 Conclusion and Recommendations
Oct 21, 2024 · 28 min
Season 1, Episode 21: Developing an Empowering Culture with Dewey McLin
Season 1, Episode 21: Developing an Empowering Culture with Dewey McLin Welcome back to the Pharmaverse!! This week we are sitting down with The incredible Dewey McLin, and it is a real treat. In this conversation, Dewey McLin, Vice President of Medical Affairs at Longboard Pharmaceuticals, discusses his career journey, leadership best practices, and the unique approach to building a highly productive team and culture. He emphasizes the importance of creating a safe and supportive environment where people feel comfortable and empowered to grow. How important it is to meet a new hire outside of a work environment, "I always have a meal with someone that I'm gonna hire." Dewey also shares insights on hiring for a small company and the value of specific feedback and mentorship. "Sometimes 85% perfect, especially when you're trying to hit a deadline." He concludes by discussing Longboard Pharmaceuticals' innovative approach to drug development and the challenges of hiring outside the US. Takeaways 🧷 Create a safe and supportive environment where people feel comfortable and empowered to grow. ✅ Hiring for a small company requires finding people who can fill multiple roles and have the potential for growth. 🧩Avoid mis-hires by being disciplined in the hiring process and waiting for the right fit. 📈Give specific feedback and wrap it with recognition and support to help people feel empowered for growth. 💊Take a unique and inclusive approach to drug development, considering the needs of different patient populations. 🌎Plan early and be aware of the unique requirements and challenges when hiring outside the US. Chapters 00:00 Career Journey and Leadership Best Practices 08:10 Building a Highly Productive Team and Culture 19:26 Hiring for Small Companies and Avoiding Mis-Hires 22:17 Specific Feedback and Empowering Growth 25:24 Inclusive Drug Development and Unique Approaches 29:47 Challenges and Best Practices for Hiring Outside the US
Oct 7, 2024 · 29 min
Season 1, Episode 20: Breakthrough for Frontotemporal Dementia with Chris Witowski
Episode 20: Breakthrough for Frontotemporal Dementia with Chris Witowski Welcome back to the Pharmaverse Podcast! This week our host Michael Pietrack sits down with the Co-founder and CEO of Psilera Chris Witowski! If you're interested in the cutting edge of Dementia treatment this episode is for you! Listen as we discuss the company's work in the neuroplastogen space and their development of new drugs based on the mechanism of psychedelics. Psilera is focused on creating neuroplastogens that have the benefits of psychedelics without the hallucinogenic effects. They are targeting hard-to-treat neurological disorders, such as frontotemporal dementia, and aim to provide patients with at-home treatments that have fewer side effects. Witowski also discusses the changing perception and stigma around psychedelic medicine and the potential for a new era in neuroscience. Evens saying psychedelic's are, "Changing Everything We Know About Neuroscience" Tune in to hear more!! 📗 Key Moments: 🗝🔑 💊Psilera is developing neuroplastogens, which are drugs based on the mechanism of psychedelics but without the hallucinogenic effects. 🧪Their lead drug, SIL-006, is being developed for the treatment of frontotemporal dementia, a condition with no available treatments. 🏡Psilera aims to provide at-home treatments that have fewer side effects, making them more accessible to patients. 👨‍🔬There is a changing perception and decreasing stigma around psychedelic medicine, with the potential for a new era in neuroscience. ⚙The future of psychedelic medicine looks promising, with several drugs expected to be on the market in the next five to ten years. 📗 Chapters 00:00 Introduction and Discussion on Recording Platform 03:02 Origin of Psilera's Name and Website Redesign 06:00 Founding of Psilera and Focus on Neuroplastogens 08:24 Neuroplastogens: Rewiring the Brain for Lasting Benefits 10:31 Potential Applications of Neuroplastogens in Anxiety and Psychiatry 16:24 The Renaissance of Neurology and the Future of Psychedelic Medicine 19:00 Targeting Frontotemporal Dementia: Unmet Medical Need and Potential Impact 23:16 The Changing Perception of Psychedelic Medicine and the New Era in Neuroscience 27:27 Career Development and Pivotal Moments 29:14 Life Lessons from Working at a Startup
Sep 23, 2024 · 28 min
Season 1, Episode 19: Focus On "We" Not "I" with Melissa Mims
Welcome back to the Pharmaverse! 💉 In this episode of the Pharmaverse podcast, host Michael Pietrack interviews Melissa Mims, the AVP of US Medical Affairs with Merck Oncology. Melissa shares her journey from drug discovery to field medical affairs and offers insights on leadership and team culture. She emphasizes the importance of building peer-to-peer leadership and establishing trust with team members. Melissa also discusses the need for leaders to listen, take feedback, and communicate the impact of their team's work. "People don't leave organizations, they leave managers." She encourages leaders to bring their authentic selves to work and create a culture where people feel appreciated and motivated. "Focus on 'we' not 'I' in leadership. The episode concludes with Melissa's advice on hiring and interviewing, focusing on finding individuals who align with the organization's mission and values. Takeaways: 🗝 🧤Build peer-to-peer leadership and establish trust with team members. 🔊Listen to feedback and communicate the impact of your team's work. 💕Bring your authentic self to work and create a culture where people feel appreciated and motivated. ✅When hiring, look for individuals who align with the organization's mission and values. Chapters 00:00 Introduction and Background 02:11 Transitioning from Peer to Manager 06:25 Putting on a New Set of Ears 09:22 Establishing Trust and Credibility 13:36 Being Your Authentic Self as a Leader 16:29 Collaborative Leadership and Minimizing the Ego 21:16 Creating a Culture of Trust and Appreciation 26:21 Hiring for Alignment with Mission and Values 29:10 Conclusion
Sep 9, 2024 · 36 min
Season 1, Episode 18: Challenges Facing the Pharma Universe with Jack West
In this episode of the Pharmaverse podcast, host Michael Pietrack interviews Jack West, the VP of Clinical Development at Summit Therapeutics. They discuss Jack's transition from being a practicing oncologist to working in the pharmaceutical industry, the importance of collaborations with pharma, and the challenges and rewards of working in a small pharma company. "Going into a pharma company is like riding a mechanical bull. The directions change frequently and sometimes you're not ready for them." Jack also shares his insights on leadership best practices and the top challenges facing the pharma industry. "Having well-defined roles and a clear value is important in leadership." The episode concludes with a discussion on Summit Therapeutics' recent positive press releases and Jack's social media presence. Takeaways: 🤝Collaborations with pharma can be instrumental in making the leap from clinical practice to the pharmaceutical industry. 💹Transitioning from clinical practice to pharma requires a willingness to adapt to new priorities and challenges. 🕴Leadership in the pharmaceutical industry requires well-defined roles, clear value, and a culture of open communication and dissent. 💊The pharma industry faces challenges such as evolving regulatory approvals, acceptance of data from different regions, and incorporating patient perspectives. 🐟Working in a small pharma company offers agility, involvement in various processes, and the opportunity to make a significant impact. 👐Stay open to new perspectives and be willing to modify your opinions based on new information. 🩺Adapt to the evolving regulatory landscape and consider the challenges of generalizing data from different regions. 🏥Recognize the changing role of patients in decision-making and incorporate their perspectives and priorities. 💉Embrace the opportunities for growth and learning in a small company environment. 💊Be bold, clarify your goals, and actively pursue your desired path. Chapters 00:00 Introduction and Background 03:08 Transitioning from Clinical Practice to Pharma 10:45 Leadership Best Practices in the Pharma Industry 18:03 Challenges Facing the Pharma Universe 28:00 The Rewards of Working in a Small Pharma Company 36:12 Summit Therapeutics' Positive Press Releases 37:03
Aug 19, 2024 · 23 min
Season 1, Episode 17: Disrupting Drug Pricing with Mark Cuban
Welcome back to the Pharmaverse! Today's episode is a special one. Michael Pietrack our host sits down with THE Mark Cuban, world famous entrepreneur, owner of the Dallas Mavericks, a 'shark' on the beloved series Shark Tank, and most excitingly for our viewers, the co-founder of Cost Plus Drug Company. In this episode we discuss the need for transparency in the drug pricing landscape and how his company is disrupting the market. He explains that Cost Plus Drugs is a completely transparent pharmacy that shows the price, cost, and markup of medications. By offering lower prices and providing transparency, Cost Plus Drugs is making a significant impact on people's lives. Mark also shares his insights on leadership and building a winning culture. "We launched and what made us different is not only did we show you the price, something others had done a little bit, but we also showed you our cost." He heart-warmingly shares stories of patients whose lives have been changed forever by cost plus, saving them thousands of dollars a month, and allowing them to stop rationing their medications. Truly an incredible episode! Tune in. 🗝Key Moments: 👀Transparency is crucial in the pharmacy industry, and Cost Plus Drugs is disrupting the market by providing complete transparency in pricing and costs. 💊Cost Plus Drugs offers lower prices for medications, making them more affordable for people and improving their access to necessary drugs. 💕Mark Cuban emphasizes the importance of caring and aligning the mission of the organization with the employees' goals to be a good leader. 📈Creating a winning culture involves understanding the product or service being offered, selling the experience, and appreciating the contributions of all team members. 👫Mark's proudest leadership moment is not winning a championship in sports, but the potential impact of Cost Plus Drugs in making medications more affordable for everyone. Chapters 00:00 Introduction and Background 02:42 Transparency in the Pharmacy Industry 06:09 Disrupting the Market and Challenging PBMs 08:56 The Impact of Cost Plus Drugs on Local Pharmacies 13:35 Word of Mouth Marketing and Success 22:11 Leadership and Building a Winning Culture
Aug 6, 2024 · 24 min
Special Edition Episode: Howard Matalon does a deep dive on Non-Competes!
In this special edition of the Pharmaverse podcast, host Michael Pietrack sits back down with Howard Matalon, an employment attorney and executive coach, about the recent FTC rule that may change the landscape of non-competes. Tune in to hear a deep dive on non-competes! The FTC rule, which goes into effect on September 4, 2024, declares non-competes to be an illegal restraint of trade. However, the rule has faced legal challenges and its fate is uncertain. Matalon advises senior executives to be cautious about new non-competes and suggests that existing non-competes may be null and void after the rule goes into effect. He also discusses the importance of defining the scope, duration, and geography of non-competes to ensure their enforceability. Howard's advice, "In the new reality, a non-compete would be really inapplicable for someone who is not considered a senior executive." Tune in to learn more! Takeaways: ⚖The FTC rule, set to go into effect on September 4, 2024, declares non-competes to be an illegal restraint of trade. 📑The fate of the FTC rule is uncertain, as it is currently facing legal challenges. 👆 Senior executives should be cautious about new non-competes and existing non-competes may be null and void after the rule goes into effect. 🛑Defining the scope, duration, and geography of non-competes is crucial for their enforceability. Chapters 00:00 Introduction and Background 03:40 Effective Date and Uncertainty 07:03 Impact on Senior Executives 12:09 Potential Supreme Court Ruling 18:05 Ensuring Enforceability of Non-Competes 20:22 Dealing with Broad Non-Competes 23:21 Seeking Legal Advice on Non-Competes 25:06 Conclusion
Jul 22, 2024 · 35 min
Season 1, Episode 15: Leading by Example with Leslie Meltzer
Welcome back to the Pharmaverse podcast! We are so excited to sit down with Leslie Meltzer, Chief Medical Officer at Orchard Therapeutics, shares her career journey and offers insights for aspiring leaders in the pharmaceutical industry. "My successes are all team successes." She emphasizes the importance of teamwork and acknowledges that her successes are team successes. Leslie discusses how she broke into the industry and quickly advanced in her first role by focusing on bringing value to her colleagues and building strong relationships. She also shares tips for leading in a therapeutic area where you may not be the expert, including the importance of continuous learning and building relationships with key opinion leaders. Leslie highlights the value of being a person of value and the importance of humility in leadership. She also discusses her experiences transitioning into different therapeutic areas and offers advice for landing a job in a different area. Finally, Leslie talks about the challenges of being a CMO and the transition from functional leadership to enterprise leadership. Takeaways 💹Success in the pharmaceutical industry is a team effort, and it's important to acknowledge and appreciate the contributions of others. 🏗 To advance in your career, focus on bringing value to your colleagues and building strong relationships. 👨‍⚕️ When leading in a therapeutic area where you may not be the expert, prioritize continuous learning and building relationships with key opinion leaders. ✅Being a person of value and demonstrating humility are key traits for successful leadership. 💉When transitioning into a different therapeutic area, emphasize your track record of versatility and your ability to quickly learn and adapt. 🤝As a leader, think beyond your own department and consider the overall success of the company. Build relationships and bring value to the organization as a whole. Chapters 00:00 Introduction 01:25 The Power of Teamwork and Acknowledging Success as a Team 05:15 Bringing Value and Building Relationships for Career Advancement 08:26 Leading in a Therapeutic Area Where You're Not the Expert 11:46 The Importance of Continuous Learning and Humility in Leadership 20:25 Transitioning into Different Therapeutic Areas: Versatility and Adaptability 29:38 From Functional Leadership to Enterprise Leadership: Thinking Beyond Your Department
Jun 24, 2024 · 29 min
Season 1, Episode 14: Building High Performing Teams with Eva Gallagher
In this episode, Eva Gallagher, VP and Head of Medical Affairs at Agios, shares her insights on building teams and creating a supportive culture in the pharmaceutical industry. She emphasizes the importance of having a good relationship with your manager and the benefits of following a manager to a new company. Eva also discusses her recipe for building high-performing teams, which includes effective communication, camaraderie, and understanding each team member's motivations. She highlights the value of nurses in the industry and shares her passion project, RN to Pharma, which helps nurses transition to careers in biotech and pharma. Eva concludes with career advice for aspiring leaders, encouraging them to say yes to development opportunities and be deliberate in networking and advocating for themselves. Takeaways 🤗Having a good relationship with your manager can make a significant impact on your job satisfaction and career development. 🏗 Building high-performing teams requires effective communication, camaraderie, and understanding each team member's motivations. 🤝Creating a supportive culture involves making time for team members to get to know each other personally and fostering an environment where they can bring their whole selves to work. ✅When hiring, look for candidates who are a cultural fit and can bring something new and valuable to the team. 👩‍⚕️Nurses bring valuable skills to the pharmaceutical industry, including clinical expertise, patient advocacy, and strong soft skills. 🏥 RN to Pharma is a resource that helps nurses transition to careers in biotech and pharma. 📈 Aspiring leaders should say yes to development opportunities, be deliberate in networking, and advocate for themselves. Chapters 00:00 Introduction and Background 01:15 Benefits and Pitfalls of Following a Manager 04:09 Creating a Supportive Culture 07:41 Hiring Strategies and Cultural Fit 09:01 Effective Interviewing Techniques 12:16 The Importance of Diversity in Hiring 13:30 Onboarding and Supporting New Employees 15:19 Defining and Cultivating Company Culture 20:17 Transitioning Between Therapeutic Areas 23:28 The Value of Nursing Background in Leadership 25:12 RN to Pharma: Helping Nurses Transition to Industry 27:13 Career Advice for Aspiring Leaders 29:07 Conclusion
Jun 10, 2024 · 28 min
Season 1, Episode 13: Leadership Through Vulnerability with Gwen Binder
Welcome back to the Pharmaverse podcast! In today's episode our host Michael Pietrack sits down with Gwendolyn Binder, President of Science and Technologies at Cabaletta Bio, shares her insights on leadership. She discusses how she became an accidental leader and the importance of focusing on advancing the ball for patients rather than personal recognition. Binder emphasizes the need for leaders to embrace uncertainty and have an entrepreneurial attitude. She also highlights the importance of unleashing the potential of others and aligning a unified vision. Binder discusses the role of culture in leadership and the need for leaders to be vulnerable and create a teamwork culture. She provides tips for hiring and emphasizes the importance of no-regret hires. "Instead of trying to think how can I climb the ladder, it's how can I be of most use continually?" Binder also addresses the challenges and advice for female leaders. Tune in to hear it all! Takeaways 🏀Focus on advancing the ball for patients rather than personal recognition. 🤗Embrace uncertainty and have an entrepreneurial attitude. 💹Unleash the potential of others and align a unified vision. ➡⬅Create a teamwork culture by being vulnerable and open. ☑Make no-regret hires by assessing cultural fit and soft skills. 🚺Acknowledge and address the challenges faced by female leaders. Chapters 00:00 Introduction and Background 06:26 Transitioning from Individual Contributor to Leader 10:53 Deprogramming Ego and Shifting Focus 23:13 Challenges and Advice for Female Leaders 27:40 Conclusion
May 27, 2024 · 18 min
Season 1, Episode 12: The Future of Immuno-Oncology with Mark Frohlich
We are thrilled to be joined this week by Mark Frohlich, a Harvard-trained medical oncologist and CEO of Indapta on the Pharmaverse! He discusses his experience in the pharmaceutical industry and the challenges and advancements in immunotherapy. He emphasizes the importance of understanding the immune system and the need for cryopreservation in cell therapies. Frohlich also discusses the future of immunotherapy, including the integration of different approaches and the role of artificial intelligence. "For cell therapies, it needs to be cryopreserved to be really commercially viable." As a CEO, he highlights the importance of focusing on tasks that only he can do, giving honest feedback, and seeking out mentors for career development. Key Points: 👨‍⚕️ Understanding the immune system is crucial in developing effective immunotherapies. 💉Cryopreservation is essential for the commercial viability of cell therapies. 🔜The future of immunotherapy lies in integrating different approaches and leveraging artificial intelligence. ✋As a CEO, focus on tasks that only you can do and delegate other responsibilities. 🔰Give honest and direct feedback to help employees perform at their best. 📚Seek out mentors for guidance and career development. Chapters 00:00 Introduction to Mark Froehlich and his Background in Immunotherapy 03:07 The Future of Immunotherapy: Integration and AI 06:18 Mark Froehlich's Transition from Engineering to Medicine 08:00 The Role of Engineering in Drug Development 11:14 Leadership Best Practices for CEOs 13:05 The Importance of Honest Feedback
May 13, 2024 · 33 min
Season 1, Episode 11: Patient-Centered Care with Rebecca Vermeulen
Welcome back to the Pharmaverse with Michael Pietrack! This week we sit down with the incredible Rebecca Vermeulen, VP of Global Patient Networks at Roche, shares insights on leadership challenges, leading international teams, creating an inclusive culture, hiring great MSLs, empowering women in leadership, and navigating up within a company. She also discusses her involvement with the Patient Focused Medicines Development Organization. Takeaways: 🤝Invest time in understanding cultural similarities and differences when leading international teams. 💝Create a safe and inclusive environment for team members to be themselves. 👂Practice active listening and give undivided attention to others. 🧮Take calculated risks and be open to moving locations for career growth. 💪Focus on innate talents and strengths when hiring MSLs. 👭Empower women in leadership by encouraging authenticity and vulnerability. 💹Define what you want to be and focus on long-term goals within a company. 👍Get involved in organizations like the Patient Focused Medicines Development Organization to drive meaningful change. Chapters 00:00 Introduction and Role of VP of Global Patient Networks 03:37 Leadership Challenges in Leading an International Team 09:32 Insights on Leading an International Team 13:20 The Value of Diversity in International Teams 14:51 Creating an Inclusive Culture 16:31 The Importance of Active Listening 17:17 The Power of Undivided Attention 19:30 The Benefits of Moving Locations for Career Growth 22:42 Hiring Great MSLs 26:45 Empowering Women in Leadership 30:16 Navigating Up Within a Company 32:27 Involvement with Patient Focused Medicines Development Organization
Apr 29, 2024 · 30 min
Season 1, Episode 10: Pursuing Dreams with Michael Cox
Welcome to episode 10 of the Pharmaverse! We are thrilled to bring you Michael Cox, a leader in the pharmaceutical industry, who shares his journey and insights in this conversation. Learn about his transition from clinical operations to medical communications and the risks he took to pursue his dreams. He also talks about his experience leading teams in the U.S. and Europe and the challenges of working in the pediatric space. Throughout the conversation, Cox emphasizes the importance of having a dream, empowering others, and leaving the world a better place. Tune in for this great episode! Key Takeaways: 🔑 📈Take risks and pursue your dreams, even if it means pivoting your career. 💟Empower and hire people who are smarter than you. ☝Be a servant leader and show empathy towards your team. 🌍Leave the world a better place than you found it. Chapters 📚 00:00 Introduction of Michael Cox 03:16 Pivoting from Clinical Operations to Medical Communications 05:39 Taking a Risk and Moving Overseas 08:35 Leading Teams in the U.S. vs. Europe 11:39 Leading an International Team 13:47 Taking a Risk and Joining Loxo Oncology 16:54 Moving to a Startup Setting 19:40 Joining Day One Biopharmaceuticals 23:37 Challenges in the Pediatric Space 29:40 Advice for Career Growth and Leadership
Apr 15, 2024 · 30 min
Season 1, Episode 9: Career Insights From a CEO with Mark Erlander
Welcome back to the Pharmaverse podcast! We are thrilled to welcome Mark Erlander PHD, CEO of Cardiff Oncology, shares his journey from a PhD in neuroscience to leading an oncology company. He discusses the calculated risks he took throughout his career and the importance of following your passion. Erlander emphasizes the need for leaders to be motivated and to create a team that is excited to work together. "Create a motivated team by fostering trust, respect, and providing resources" He tells up and comers to do something they are truly excited about, but also be be opportunistic and willing to take calculated risks. We jump in to discussions on the future of cancer treatments, including targeted therapies and personalized medicine. Key Points: ❇Follow your passion and do something you are truly excited about 🤗Create a motivated team by fostering trust, respect, and providing resources 📈Be opportunistic and willing to take calculated risks ❌Never settle for something that is less than what you want to achieve 💊The future of cancer treatments includes targeted therapies and personalized medicine ✨ Chapters ✨ 00:00 Introduction to Mark Erlander 01:01 Taking Calculated Risks in Career Choices 06:10 Transitioning to the Oncology Space 09:00 Shifting Strategy Based on Data 11:58 The Future of Cancer Treatments 15:31 Leadership Nuggets from Mark Erlander 26:07 Advice for Aspiring Leaders 29:01 Closing Remarks and Plug for Cardiff Oncology
Apr 8, 2024 · 33 min
Season 1, Episode 8: Equity and Diversity in Clinical Trials with Camille Pope
Welcome back to the Pharmaverse podcast with Michael Pietrack! We are joined today by Camille Pope, Chief Medical Lead at Acclinate, discusses the importance of diversity in clinical research and the impact of a health equity lens. She highlights regulatory and legal developments in clinical trial diversity and addresses the factors contributing to mistrust and exclusion in clinical trials. Pope also provides insights on how pharmaceutical leaders can engage with underrepresented communities and set up diverse clinical trials. Her leadership tip emphasizes the importance of mastering one's current role and striving for excellence. 🔬 Diversity, inclusion, equity, and health equity are key components in addressing clinical trial diversity. 💊 A health equity lens benefits both patients and pharmaceutical companies by ensuring safe and efficacious drugs for all populations. 📝 Regulatory and legal developments, such as FDA guidance and legislation, mandate pharmaceutical companies to prioritize diversity in clinical trials. ❌ Mistrust and exclusion are significant barriers to diversity in clinical trials, and understanding the historical context and validating community experiences is crucial. 🧠 Biases, assumptions, and lack of education contribute to the lack of diversity in clinical trials and should be addressed. 🤝 Engaging with underrepresented communities requires genuine partnerships, community involvement, and trust-building efforts. 🏢 Internal strategies for setting up diverse clinical trials include collaboration across functional areas and leveraging existing knowledge and resources. 🎯 Leaders should strive for excellence in their current roles and master the necessary skills before seeking new opportunities. Chapters 00:00 Introduction to Camille Pope and her focus on diversity in clinical research 07:02 Breaking down the acronym DE&I (Diversity, Inclusion, Equity, and Health Equity) 09:33 The impact of health equity lens on patients and pharmaceutical companies 14:47 Regulatory and legal developments in clinical trial diversity 19:03 The importance of addressing mistrust and exclusion in clinical trials 23:07 Other factors contributing to lack of diversity in clinical trials 26:15 Engaging with underrepresented communities as a pharmaceutical leader 29:28 Internal strategies for setting up diverse clinical trials 32:42 Leadership tip: Master your current role and strive for excellence
Apr 1, 2024 · 30 min
Season 1, Episode 7: Clinical Trials and Drug Development with Ken Getz
Welcome back to the Pharmaverse! In this episode, host Michael Pietrack interviews Ken Getz, an expert in drug development and a professor at Tufts School of Medicine. They discuss various topics related to clinical trials and drug development, including managing complexity, reducing costs, the impact of AI, challenges in patient enrollment and retention, high failure rates in phase III trials, and the impact of the pandemic on clinical trials. Ken also talks about the work of the Center for Information and Study of Clinical Research Participation (CISCRIP) and how listeners can support their cause. Listen in to learn about Clinical Trials and Drug Development from Ken! Takeaways: 💊Managing the growing complexity of drug development is crucial for optimizing the process. 💉Reducing drug development costs is a challenge, with factors such as patient recruitment and retention contributing to high expenses. ⚙AI has the potential to reduce costs and improve various aspects of drug development, including patient identification and adverse event prediction. 👨‍⚕️Challenges in patient enrollment and retention, as well as high failure rates in phase III trials, impact the success of drug development. 🏥The COVID-19 pandemic has affected clinical trials, leading to delays and changes in enrollment. 🤝Supporting organizations like the Center for Information and Study of 🖐Clinical Research Participation (CISCRIP) can help educate the public and improve patient engagement in clinical research. Sound Bites Chapters 00:00 Introduction to Ken Getz 01:01 Ken Getz's Background and Involvement in Clinical Trials 03:13 Managing the Growing Complexity of Drug Development 05:11 Reducing Drug Development Costs 07:51 The Impact of AI on Drug Development 13:25 Challenges in Patient Enrollment and Retention 16:01 High Failure Rates in Phase III Trials 19:33 Collaborating with Tufts CSDD 21:48 The Impact of the Pandemic on Clinical Trials 26:44 Supporting the Center for Information and Study of Clinical Research Participation (CISCRIP) 29:08 Closing Remarks and Gratitude